Seikagaku Corporation Japan Company Profile
Arthritis Therapies
Location
1-5 Nihonbashi Hon-cho 2-chome, Chuo-ku
Tokyo
Tokyo
103
Japan
Contact
Phone: 81 3 3270 0966
Fax: 81 3 3270 0538
News Articles
Business in Japan versus to Japan, by P Reed Maurer
A pharmaceutical company without a presence in Japan but with a hot new product ready for Phase III clinical trials, and several compounds in preclinical testing has two options vis a vis the Japan ma...
Last week’s exclusive partnership with Mylan has put Japan in a much stronger position in Japan’s generics market. The question remains whether it can navigate Japan’s unique Gx challenges.
Is Japan an ideal pharma market? - by P Reed Maurer
An uninformed, non-resident of Japan might respond to the title question as the Chairman of a major multinational pharma company did in July, comments long-time Japan industry watcher P Reed Maurer, p...
Pakistan Drug Makers Seek Business With Japan Counterparts
Pakistan is sending a 13-member delegation comprised mostly of drug company officials to Japan to talk about possible collaborations with Japan pharmaceutical companies.
Filing sets up JT's HIV quad pill to be first of its type in Japan
Japan Tobacco (JT) is looking to become the first company to commercialize in Japan a once-daily, single-tablet combination regimen for HIV following a filing for its four-in-one therapy. The produc...
Retina Institute Japan K.K. (RIJ) (Hauptsitz: Fukuoka, Japan; Präsident: Hardy T S Kagimoto, MD) und Dainippon Sumitomo Pharma Co., Ltd. (DSP) (Hauptsitz: Osaka, Japan; Präsident: Masayo Tada) hat.....
JT's Zerenex filing set to up ante in competitive Japan binder market
Japan Tobacco's (JT) approval filing in Japan for JTT-751 (ferric citrate; licensed from Keryx Biopharmaceuticals) for the treatment of hyperphosphatemia in patients with chronic kidney disease (CKD)...
Japan 2012 Medical Market Led By Antibodies, DPP-4s: IMS
In a study on domestic pharmaceutical markets in Japan carried out by IMS Japan, the anti-tumor drug market ranked highest for Jan-Dec. 2012 with sales at ¥653.5 billion.
Drugs and Medications
Dhc hand [DHC USA Incorporated]
DHC Hand Soap Antiseptic handwash
Oil-free daily hydration spf 15 [Boscia LLC]
Oil-Free Daily Hydration SPF 15
Icy hot arm neck leg and small areas [Chattem, Inc.]
Icy Hot - Patch
Icy hot medicated roll medium [Chattem, Inc.]
Icy Hot - Roll
Brighter by nature spf 30 [JO Cosmetics Co., Ltd.]
Brighter By Nature™ SPF 30
PubMed Articles
The alpha2,6-sialylated blood group type 2 H (ST2H) antigen (Fucalpha 1-2(NeuAcalpha2-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc-Cer) is a fucoganglioside found in human colon cancer tissues. To elucidate...
Widespread use of neuraminidase inhibitors in Japan.
Almost all patients with an influenza-like illness in Japan are now tested with rapid diagnostic tests, and when positive, they are treated with a neuraminidase inhibitor (NAI). Japan may have had the...
Japan's new global health policy: 2011-2015.
Norepinephrine in the brain is associated with aversion to financial loss.
Clinical Trials
The purpose of this study is to evaluate the safety and tolerability of AVE0010 once daily treatment in monotherapy in type 2 diabetes patients in Japan over 76 weeks of treatment. The pr...
Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome (JAPAN-ACS)
The purpose of this study is to compare the effects of pitavastatin and atorvastatin on coronary plaque volume in patients with acute coronary syndrome and to clarify the relationship betw...
PROMUS Element Japan Small Vessel Trial
A non-randomized, small vessel (SV) trial at approximately 15 sites in Japan to enroll 60 patients with a de novo lesion ≤28 mm in length (by visual estimate) in a native coronary arte...
Japan-Drug Eluting Stents Evaluation; a Randomized Trial
To evaluate the procedural, short and long term clinical outcomes of the TAXUS stent compared to Cypher stent in coronary arteries of ≥ 2.5 and ≤ 3.75 mm in the reference vessel diamet...
Dose Escalation Study of AUY922 in Advanced Solid Malignancies in Japan
This study will characterize the safety, tolerability, efficacy, pharmacokinetics, and pharmacodynamics of AUY922 in adult patients with advanced solid malignancies in Japan.
Companies
Seikagaku America Incorporated
Seikagaku America is the US subsidiary of Seikagaku Corporation...The Pioneer of Glycoscience! We are a primary supplier of unique and high quality research biochemicals for Carbohydrate Chemistry, Mo...
Arthritis Therapies
Nil
S.T. Japan USA, LLC is the American branch of S.T. Japan, Inc. . It is a member of the S.T. Japan Group. Our main functions and activities are:To directly sell to End-Users located in the USA and the...
Since its inception in 1985, the Japan Prize Foundation has awarded the Japan Prize to 70 people from 13 countries. In addition to awarding the Japan Prize, which is endorsed by t...
More Information about "Seikagaku Corporation Japan" on BioPortfolio
We have published hundreds of Seikagaku Corporation Japan news stories on BioPortfolio along with dozens of Seikagaku Corporation Japan Clinical Trials and PubMed Articles about Seikagaku Corporation Japan for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Seikagaku Corporation Japan Companies in our database. You can also find out about relevant Seikagaku Corporation Japan Drugs and Medications on this site too.
